199 related articles for article (PubMed ID: 29229640)
1. Adverse Effects of Intravenous Vancomycin-Based Prophylaxis during Therapy for Pediatric Acute Myeloid Leukemia.
Sun Y; Huskey RL; Tang L; Inaba H; Gaur AH; Ribeiro R; Rubnitz JE; Wolf J
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229640
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
5. Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection.
Zhang K; Beckett P; Abouanaser S; Stankus V; Lee C; Smieja M
BMC Infect Dis; 2019 Jan; 19(1):51. PubMed ID: 30642269
[TBL] [Abstract][Full Text] [Related]
6. Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.
Rubio-Terrés C; Cobo Reinoso J; Grau Cerrato S; Mensa Pueyo J; Salavert Lletí M; Toledo A; Anguita P; Rubio-Rodríguez D; Watt M; Gani R
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2213-23. PubMed ID: 26407619
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
Carignan A; Poulin S; Martin P; Labbé AC; Valiquette L; Al-Bachari H; Montpetit LP; Pépin J
Am J Gastroenterol; 2016 Dec; 111(12):1834-1840. PubMed ID: 27619835
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents.
Van Hise NW; Bryant AM; Hennessey EK; Crannage AJ; Khoury JA; Manian FA
Clin Infect Dis; 2016 Sep; 63(5):651-3. PubMed ID: 27318333
[TBL] [Abstract][Full Text] [Related]
9. Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant.
Altemeier OJ; Konrardy KT
Transpl Infect Dis; 2022 Apr; 24(2):e13790. PubMed ID: 35014136
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Poeran J; Mazumdar M; Rasul R; Meyer J; Sacks HS; Koll BS; Wallach FR; Moskowitz A; Gelijns AC
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):589-97.e2. PubMed ID: 26545971
[TBL] [Abstract][Full Text] [Related]
11. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.
Caroff DA; Menchaca JT; Zhang Z; Rhee C; Calderwood MS; Kubiak DW; Yokoe DS; Klompas M
Infect Control Hosp Epidemiol; 2019 Jun; 40(6):662-667. PubMed ID: 31030679
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
14. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of Clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea].
Cheng G; Li Z; Dai X; Wang Z; Cai P; Chen L; Zhang Z
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):220-4. PubMed ID: 26165021
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
17. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
18. Fidaxomicin--the new drug for Clostridium difficile infection.
Vaishnavi C
Indian J Med Res; 2015 Apr; 141(4):398-407. PubMed ID: 26112840
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-associated Nephrotoxicity and Risk Factors in Critically Ill Children Without Preexisting Renal Injury.
Feiten HDS; Okumura LM; Martinbiancho JK; Andreolio C; da Rocha TS; Antonacci Carvalho PR; Pedro Piva J
Pediatr Infect Dis J; 2019 Sep; 38(9):934-938. PubMed ID: 31232892
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
